Latest Breaking News On - Andrew reardon - Page 1 : comparemela.com

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) shares dropped 8.8% during trading on Tuesday . The company traded as low as $79.97 and last traded at $80.21. Approximately 82,870 shares were traded during trading, a decline of 47% from the average daily volume of 156,157 shares. The stock had previously closed at $87.91. Analysts […]

Andrew reardonNancy ryan grayBarclays plcHightower advisorsLigand pharmaceuticals incorporatedSecurities exchange commissionNews ratings for ligand pharmaceuticals dailySwiss national bankVictory capital management incLigand pharmaceuticals stock downCharles schwab investment management incInstitutional investors weigh in on ligand pharmaceuticalsLigand pharmaceuticalsGet free reportPharmaceuticals stock downDirector nancy ryan gray